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1. Introduction
Urinary tract infection (UTI) is the most commonly diagnosed bacterial infections of child‐
hood, and have a significant healthcare impact. Renal parenchymal infection and scarring
are well-established complications of UTI in children and can lead to renal insufficiency, hy‐
pertension and renal failure. Although frequently encountered and well researched, diagno‐
sis and management of UTI continue to be a controversial issue with many challenges for
the clinician [1].
Dysfunctional voiding (DV) imposes a considerable social, developmental and physical bur‐
den on children and their families. Children that suffer from DV generally present with
complaints of UTI, incontinence, constipation and voiding symptoms such as urinary urgen‐
cy and frequency. Vesicoureteral reflux (VUR) may also be present in some children with
more severe DV, possibly resulting in hydronephrosis, pyelonephritis and even secondary
chronic renal insufficiency [2].
The true estimate of DV in the general population is not known. Reported population es‐
timates of DV are based on questionable methodology. A wide variation from 4.2-46.4%
has been reported depending on the definition used and the methodology adopted [3, 4].
It  is  probable that  these figures represent a gross overestimate of  the actual  prevalence.
In tertiary care centres,  DV constitutes  up to 40% of  referrals  in  the Paediatric  Urology
department [2, 5].
This chapter will focus on the epidemiology, diagnosis and management of DV and UTI in
neurologically and anatomically normal children. The discussion will highlight recent devel‐
opments and research in the clinical approach of DV and UTI.
© 2013 Kibar and Gok; licensee InTech. This is an open access article distributed under the terms of the
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2. Definitions and classification
Children with  significant  lower  urinary  tract  symptoms without  associated neurological
or  anatomical  abnormalities  are  considered  to  have  non-neurogenic  (idiopathic)  lower
urinary tract  dysfunction (LUTD).  It  represents  a  disturbance of  the lower urinary tract
dynamics  affecting  urine  storage  or  emptying  and  can  simply  be  categorized  into  two
types in children [2, 6]:
1. Problems related to the filling (storage) phase include overactive bladder (OAB) syn‐
drome, functional urinary incontinence, and giggle incontinence.
2. Disturbances of the emptying (voiding) phase include dysfunctional voiding (DV), lazy
bladder syndrome, Hinman syndrome, and post-void dribbling.
Confusion can occur in identifying these syndromes as they may exist as a single entity or in
combination and can be progressive.
Overactive bladder (OAB) syndrome, which is the most common pattern in children with
LUTD, includes involuntary detrusor contractions and urethral instability. In children, OAB
is the result of sudden and overwhelming urge to void that requires immediate urethral
compression by the pelvic floor or by external manoeuvres such as the Vincent curtsy. This
syndrome may also result in constipation from chronic pelvic musculature contraction [2].
OAB is thought to be due to a delay in acquisition of cortical inhibition over uninhibited de‐
trusor contractions in the course of achieving the mature voiding pattern of adulthood. Ab‐
normal overactivity of the pelvic floor musculature during voiding, instead of a complete
relaxation, results in interrupted micturation [7]. The diagnosis of OAB syndrome can be
made on examining the history of incontinence related to urgency, and does not require uro‐
dynamic evidence of uninhibited detrusor activity.
Functional urinary incontinence is the failure of the sphincteric mechanism to maintain con‐
tinence in anatomically normal children. True stress urinary incontinence in which there is
an anatomic insufficiency of the sphincteric mechanism to hold urine in transmission of ab‐
dominal pressures to the bladder is rare in children [2].
Giggle incontinence is almost exclusively seen in girls and is characterized by large-vol‐
ume voiding that can occur with laughing. These patients have no voiding symptoms be‐
tween episodes and no other episodes of incontinence. The diagnosis is based on history
alone and, unless there is a history of UTI, no further evaluation is needed. Although the
aetiology is not clear, this may be a centrally mediated disorder similar to another disor‐
der, cataplexy, in which an emotional event causes muscle hypotonia. Accordingly, there
is evidence that the central nervous system stimulant, methylphenidate, may be effective
in prevention of these events [8].
Dysfunctional  voiding is  an abnormal  contraction of  the voluntary sphincter  and pelvic
floor  during  voiding  that  is  thought  to  be  an  acquired  disorder  that  may  progress  to
complete loss of bladder function [9].  Voiding dysfunction has been used and is no lon‐
ger an acceptable term. This term describes malfunction during the voiding phase only.
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It  says nothing about the storage phase.  The term cannot be applied unless repeat  uro‐
flow measurements  show curves  with  a  staccato  pattern  or  unless  verified  by  invasive
urodynamic investigation [10].  Due to the abnormal contraction of  the pelvic  floor (pel‐
vic  floor  dysfunction),  constipation is  common in these children.  Dysfunctional  elimina‐
tion syndrome (DES)  is  often used to  describe  this  disorder  because this  term accounts
for  the  link  between  the  difficulty  in  voiding  and  defecation  caused  by  the  abnormal
contraction  of  the  pelvic  floor  [3].  In  recent  studies,  the  rate  of  OAB  in  children  with
LUTD was reported variously as 58% and 71%. It has been suggested that the rate of DV
is lower than that of OAB [11, 12].
Lazy bladder syndrome or myogenic failure is the loss of detrusor activity that requires the
Valsalva maneuver to fully empty the bladder [2]. This condition is seen in about 7% of all
dysfunctional voiders and typically occurs in females with a ratio of 5:1 to males [8]. Long-
term fractionated voiding is thought to be the cause of this syndrome in which long voiding
times result in loss of the normal detrusor function. Voiding is accomplished by increasing
abdominal pressure to empty. Infrequent voids, large-volume post-void residuals with over‐
flow incontinence, and UTIs are the prevalent symptoms and signs. As a rule, urodynamic
evaluation demonstrates a large-capacity, very compliant bladder; however, some of these
patients may also demonstrate a degree of detrusor overactivity [8].
Hinman syndrome or nonneurogenic neurogenic bladder (NNNB) is often interchanged
with occult neuropathic bladder and represents full decompensation of the voiding mecha‐
nism. Children will present with day and night-time incontinence, chronic UTIs, and chronic
constipation. Urodynamic studies will often show uninhibited detrusor activity during fill‐
ing, high filling pressures, large post-void residual (PVR) volumes, and abnormal activity of
the pelvic floor musculature during voiding. Imaging studies results are frequently abnor‐
mal with hydroureteronephrosis secondary to VUR being common [2].
Post-void dribbling is a disorder in which incontinence of urine occurs immediately after
micturition. This syndrome is more common in female patients and is thought to be secon‐
dary to retained urine in the vagina that leaks after standing. Even though it is more likely
to occur in obese girls it can also happen frequently in girls who are thin. This pattern can be
seen on voiding cystourethrography. This can produce irritation of the labia, dysuria as the
urine passes over the irritated skin, a reduced desire to void, incomplete emptying, and
eventually recurrent UTI with its consequent changes in bladder function that further aggra‐
vate the clinical picture. Although these symptoms usually resolve with age and normal
growth, the child may improve the symptoms more abruptly by facing backwards on the
toilet with her body tilted forward and her legs straddling the toilet, or by manually spread‐
ing the labia majora with fingers as she voids [8].
3. Aetiology and pathogenesis
The aetiology of DV in otherwise healthy, neurologically intact children remains a matter of
debate. In the absence of any neurologic or anatomic findings, the voiding patterns in DV
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are often believed to originate from behavioural issues. These behavioural traits may evolve
from adverse events that occur around or after the time of toilet training and/or personal
stresses [13]. Severe emotional stressors, such as sexual abuse mainly in girls, has been asso‐
ciated with DV, and should be considered in a child, especially a girl, who presents with
new onset DV and no other identifiable etiologic factor [4, 5].
Detrusor overactivity as a component of DV may represent a persistence of the normal in‐
fant voiding pattern after toilet training. It may be that a mild delay in the maturation of the
central nervous system disrupts the ability of these children to learn true voluntary control
over the micturition reflex [5, 14]. An alternative theory to the development of the urge syn‐
drome hypothesizes that detrusor overactivity is caused by the transient obstruction that oc‐
curs with DV [15]. In support of the belief that the roots of DV may be grounded in
behavioural issues or central nervous system developmental delays, an association has been
demonstrated between DV and attention deficit hyperactivity disorder (ADHD). Higher
rates of enuresis, urinary incontinence, constipation, and other voiding symptoms have been
described in children with ADHD [16, 17].
As a result of studies of DV diagnosed in infancy, a congenital or genetic component to
the disorder has also been postulated.  Small  series  of  infants  with signs and symptoms
consistent  with  NNNB  syndromes  have  been  reported  [18,  19].  Furthermore,  DV  has
been linked to the Ochoa syndrome,  a  genetic  disorder with an autosomal recessive in‐
heritance pattern. The gene locus at chromosome 10q23-q24 is identified as the defective
gene in Ochoa syndrome. It is postulated to be the possible gene locus of the NNNB de‐
scribed by Hinman and Allan [20].  This information casts doubt on the commonly held
belief  that  disturbance  of  behaviour  is  the  sole  cause  of  NNNB because  these  findings
are present at or near the time of birth.
At least some patients with DV represent occult  neurogenic problems that will  manifest
provided  these  patients  are  followed  longitudinally  [21].  In  all  individuals  with  unex‐
plained severe DV, search for an unidentified neurological lesion must be made. A sub‐
tle  neurological  insult  could present  as  DV. Such lesions may or  may not  be detectable
with current imaging technologies. Routine magnetic resonance imaging in children with
lower urinary tract  problems without overt neurological  signs and symptoms has a low
yield of 7.5% but this may be improved by targeting children with abnormal cutaneous
findings  [22].  Tethered  cord  syndrome  may  be  identified  in  some  patients  with  subtle
neurological signs and symptoms. Classical tethered cord has been diagnosed on the ba‐
sis of pathologically elongated conus or conus that lies below the L2 level. However, an‐
ecdotal  successful  outcomes  following  surgical  division  of  the  filum  in  children  with
apparently  normally  located cords  suggest  that  the  cord may sometimes be  abnormally
stretched without being at an abnormal location [23].  Such subtle lesions might also ex‐
plain the occasional presentation in infancy when the problem has its onset before toilet
training has commenced [19]. Surgical division of the filum terminale in such patients is
controversial but may yield improvements in bladder dysfunction [24].
Another  possible  indirect  evidence  for  an  unidentified  neurological  lesion  in  these  pa‐
tients  is  the  association  of  a  peculiar  facial  expression  in  some  children  with  DV  [25].
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The association of  facial  expression with bladder function in this  “Urofacial  Syndrome”
has been explained by the proximity of the cortical centres for the bladder and facial ex‐
pression in the brain. Presumably, this makes an association of abnormality between the
two centres more likely.
A higher than expected association of idiopathic hypercalciuria, ranging from 21-30%, has
been noted in children with DV syndromes. However, almost all responded to behavioural
therapy, dietary modifications and anticholinergics and treatment specifically directed at
hypercalciuria were needed in only two percent [26]. The reason for an association between
hypercalciuria and DV remains unclear. The authors postulated that calcium microcrystalli‐
zation may cause injury to the urothelium and this could trigger a variety of urinary symp‐
toms including DV.
It is probable that the entity DV is not homogenous and that there are several distinct aetiol‐
ogies that can lead to it. The end result is one of a dyssynergic sphincteric activity in the ab‐
sence of a clearly defined neurological reason.
4. Association of LUTD with UTI and VUR
There is not sufficient reported data on the relationship between the type of LUTD with UTI
and VUR. The earliest studies of LUTD mostly dealt with either OAB or DV. This is a some‐
what artificial distinction, as these conditions are often combined and sometimes difficult to
separate. For that reasons this association will be presented in LUTD children as a whole.
The association between LUTD and UTI has been established, though the causal relationship
is not clear. Recurrent UTI has been shown in any studies to be higher in VUR patients with
LUTD than in those without such dysfunction [3, 27, 28]. It has been demonstrated that ade‐
quate management of LUTD not only decreases the rate of UTI but also increases resolution
of the VUR [27, 29]. Traditionally, recurrent UTI and pyelonephritis have been recognized as
potential causes of permanent renal damage [30]. Current opinion is that VUR alone is not
sufficient to cause UTI or renal damage. Holland et al. reported that girls with primary VUR
followed up for 10 years, with no recurrent UTI, did not develop renal scars [31]. Linshaw
showed that VUR does not threaten the kidney as long as UTI is promptly treated [32]. The
results of these studies suggest that the association between VUR and UTI is necessary for
renal damage to occur, mainly in situations of low detrusor pressure. However, VUR may
predispose invasion of the renal parenchyma by bacteria. It has been reported that LUTD is
an important risk factor for VUR and renal damage [33]. In addition, current studies have
showed that increased intravesical pressure associated with LUTD is a primary factor for in‐
ducing reflux and renal damage [12, 34]. In patients who had UTI the presence of reflux in‐
creased the rate of renal damage [12].
VUR in LUTD is theorized to be not the result of a short mucosal tunnel,  but to be the
consequence of the high filling and voiding pressures. In patients with LUTD, uninhibit‐
ed detrusor contractions and voluntary constriction of the sphincter, causing a functional
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obstruction,  increase  the  intravesical  pressure.  Increased  intravesical  pressure  can  pro‐
mote VUR through a possible marginal competence in the valve mechanism [34, 35]. Re‐
cent  studies  have  shown  that  the  prevalence  of  VUR  among  children  with  idiopathic
LUTD is  between 14% and 46% [11,  12].  Some reports  have emphasized bilateral  reflux
associated with LUTD [12, 36].
Van Gool et al. addressed the relationship between DV and reflux for the first time with a
retrospective questionnaire in 1992 [37]. The prevalence of uncoordination between the de‐
trusor and urethral sphincter approached 18% and included voiding pattern abnormalities
such as urge syndrome, staccato voiding, fractionated and incomplete voiding, and voiding
postponement. They also found that, in those children who had spontaneous resolution of
their VUR, there was a lower prevalence of DV.
It  is  important  to  carefully  assess  all  children  with  reflux  for  subtle  signs  of  DV.  Chil‐
dren with DV are more likely to have recurrent UTIs, have mild bilateral reflux with less
spontaneous  resolution,  and  are  less  likely  to  have  success  with  surgical  management.
The treatment of DV in such children can improve the chances of spontaneous resolution
of the reflux and may also reduce recurrent urinary infection. Koff et al. [3] reported on
their series of children with VUR, who either resolved spontaneously or were surgically
treated, and found that DES was observed in 43% of children with primary VUR and in
77% of a subset of these children who had breakthrough UTI. The presence of DES pat‐
terns  was  associated with  a  longer  time for  spontaneous resolution of  low-grade reflux
and with unsuccessful surgical outcomes. Of children in the surgically treated group, on‐
ly those with DES developed recurrent and/or contralateral reflux. Children with untreat‐
ed  DV  undergoing  ureteral  re-implantation  may  be  at  a  higher  risk  for  developing
recurrent reflux or a new bladder diverticulum [38].
Contrary to these results, Chen and colleagues reported that VUR and UTI are not inde‐
pendent of DV [39]. Their findings are new observations contradicting the previous belief
that both UTI and VUR are independently associated with DES. Chen et al. performed a
multivariate analysis on 2759 paediatric urology patients, further examining the relationship
between DES, VUR, and UTI. Their data demonstrated a higher rate of DES in girls than in
boys: 43.7% compared with 23.8%. This group also found that there was no difference in the
presence of DES in patients with unilateral and bilateral VUR. Surprisingly, they observed
no association of VUR or UTI individually with DES but rather DES was only noted when
both of these issues were present. Although this large-scale multivariate analysis is a more
statistically powerful study than previous smaller retrospective analyses, the data could be
potentially skewed in that all of the patients were recruited from a paediatric urology popu‐
lation, which is not representative of the general paediatric population. Patients with known
reflux could potentially be protected from DES by prophylactic antibiotics or continued clin‐
ical follow-up in a specialty setting. On the other hand, it is suggested that there may be two
types of reflux: one that is primary or congenital in nature and another that is secondary and
in part due to DES and UTI. This study is in line with the neuroplastic theory that postulates
that hypertrophy of the bladder and bowel musculature is caused by trophic factors re‐
leased during pelvic floor hyperactivity secondary to central nervous disturbances [40]. Hy‐
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pertrophy can lead to an increase in risk factors that predispose the urinary tract to more
UTIs and more severe VUR including anatomic bladder abnormalities, constipation, in‐
creased residual urine, higher voiding pressures, and increased urethral bacteria coloniza‐
tion secondary to turbulent flow [41, 42]. Turbulent flow is of particular importance as eddy
currents formed by nonlaminar flow leads to reflux of periurethral bacteria to the proximal
urethra and bladder (milk back phenomenon), causing recurrent infections.
The pelvic floor musculature is closely related to bowel and bladder. Isolated contraction of
the pelvic floor musculature was found to lead to spontaneous contraction of the bladder.
The cycle of pelvic floor dysfunction contributing to recurrent UTIs and VUR can cause wor‐
sening bladder and bowel symptoms, and increased pelvic floor dysfunction with functional
obstruction. Eventually this can lead to a hypertrophied, small-capacity bladder with high-
pressure voiding that will lead to renal damage. The integral relationship between the pelvic
floor activity with UTIs and VUR can be used as a model for developing treatment strategies
in affected children to address the cognitive and behavioural aspects of DV and prevent irre‐
versible damage to the upper urinary tract [40].
5. Diagnosis and evaluation
Clinical symptoms may vary from mild incontinence to severe disorders with endpoints of
irreversible bladder dysfunction with VUR, UTI and resulting nephropathy [8]. Children
with DV voiding often present with urinary incontinence both during the day as well as at
night. They may have urinary frequency, urgency, urge incontinence or nocturnal enuresis.
Such storage symptoms may result from associated detrusor overactivity, urinary infection
or reduced bladder capacity consequent to large residual urine and may be aggravated by
constipation or behavioural disorders. A distinctive facial expression may be noted in some
of these patients [8].
Diagnosis relies heavily on a good history and physical examination, but also includes radi‐
ologic and urodynamic evaluation. The history should be directed towards the identification
of children with neurologic or anatomic causes of their symptoms, and then distinguish be‐
tween which form or pattern of voiding dysfunction is present. Components of this history
include maternal medical issues, perinatal history, developmental milestones, scholastic per‐
formance, behavioural history, specifics around toilet training, patterns of voiding and bow‐
el movements, history of UTI, and family history of voiding dysfunction. The use of a 3-day
voiding diary is often helpful to identify the frequency of voiding, voided volumes, and tim‐
ing of incontinent episodes [9].
Clinical examination must include an assessment of higher mental functions and their age-
appropriateness and basic neurological evaluation. On physical examination, attention
should be paid to the back and lower spine for cutaneous manifestations of an occult spinal
dysraphism and/or sacral agenesis. Neurologic examination should include assessment of
lower extremity function, rectal tone, perineal/anal sensation, and intactness of bulbocaver‐
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nosus reflex. The external genitalia should also be examined. Bowel function should be eval‐
uated in detail.
Further evaluation of the child with DV continues with a urinalysis and urine culture. The
scout film, or plain film of the abdomen (KUB), can be used to assess the spine and sacrum,
and for evidence of constipation.
A renal and bladder ultrasonography with a pre-void and post-void image should be obtained
to assess for evidence of obstructive uropathy, an ureterocele, bladder wall thickness, and re‐
sidual urine volume. Studies in healthy infants and toddlers have shown that they do not emp‐
ty the bladder completely every time but they do so at least once during a 4-hour observation
period. In older children, a consistent residual of >20 ml is considered abnormal [29].
The diagnosis of DV in children hinges upon the repeated demonstration of a staccato pat‐
tern on uroflowmetry testing. The normal uroflow pattern is a bell-shaped curve with a
smooth up-slope and down-slope. OAB may produce an explosive voiding contraction that
appears in the flow measurement as a high amplitude curve of short duration, that is, a tow‐
er-shaped curve. A child with organic outlet tract obstruction often has low amplitude and
rather even flow curve, that is, a plateau-shaped curve. Finally, in case of an underactive or
acontractile detrusor when contraction of the abdominal muscles creates the main force for
bladder evacuation, the flow curve usually shows discrete peaks corresponding to each
strain, separated by segments with zero flow, namely, an interrupted or fractionated flow
curve. The staccato pattern of voiding has been considered classical of DV. Sphincter overac‐
tivity during voiding is seen as sharp peaks and troughs in the flow curve, which is as an
irregular or staccato flow curve [10] (Figure 1). To label flow as staccato, the fluctuations
should be more than the square root of the maximum flow rate. When combined with nee‐
dle or surface EMG, increased striated urethral sphincter-pelvic floor complex activity can
be noted [9]. Less invasive uroflowmetry, perineal electromyography, and PVR comprise
the preferred modality at our institution for screening and monitoring response to treat‐
ment. Before flow study, bladder ultrasonography is used to ensure adequate volume and
exclude patients with overdistention of the bladder. Overdistention of the bladder can ob‐
scure results, causing an artificial increase in PVR volumes in normal children [43].
There have been efforts to standardize scoring systems in the evaluation of children with
DV. These scoring systems would be beneficial in classifying the type and severity of DV to
determine necessary treatment modalities. Farhat et al. introduced the Dysfunctional Void‐
ing Scoring System (DVSS) by comparing the scores of the children aged 3-10 years with
age-matched controls across 10 questions related to urinary incontinence, voiding habits, ur‐
gency, posturing, bowel habits and stressful life conditions [44]. Nine of these questions are
scored between 0 and 3 depending on whether the problem is noted almost never (0), less
than half the time (1), about half the time (2) or almost every time (3). The last question is
addressed to the parents to identify a stress situation in the family. The authors derived cut-
off values of 6 and 9 for girls and boys respectively for making a diagnosis of DV. A small
prospective cohort was analyzed by Upadhyay and colleagues to determine the validity of
the DVSS in children with reflux. A positive correlation between symptom score improve‐
ment and resolution of VUR was found [45]. Another scoring system is the “Dysfunctional
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voiding and incontinence scoring system” and designed by Akbal et al. They reported that
the children with a score of 8.5 or greater had voiding abnormalities with 90% sensitivity
and 90% specificity [46]. The last one was devised by Afshar et al, which was a 14-item 5-
point Likert scale questionnaire for children with dysfunctional elimination with a cut-off
score of 11 [47]. This questionnaire was valid and reliable for diagnosing dysfunctional elim‐
ination syndrome. The validity of these scoring systems has not yet been evaluated in large
prospective trials.
Figure 1. Example of a child with staccato flow and high EMG activity on Uroflow-EMG.
Perineal USG has been used in women with DV to assess sphincter volume [48]. Perineal
USG can also be used to evaluate paradoxical pelvic floor movement which may often be
seen in children with DV [49]. Abdominal USG has also been used for chronic constipation
in children with DV. Rectal diameter greater than 3.5 cm signifies constipation [50].
Children with DV often show abnormalities on voiding cystourethrogram (VCUG). A
VCUG may demonstrate VUR, bladder trabeculation, a diverticulum, a large bladder ca‐
pacity, or a large post-void residual. Girls may exhibit the spinning top urethra during void‐
ing, which results from dilation of the posterior urethra secondary to detrusor-sphincter
uncoordination during voiding [51] (Figure 2). Dilatation of the prostatic urethra may be ob‐
served in boys. VCUG should be performed when there is a history of recurrent UTI or a
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febrile UTI, thickened bladder wall on ultrasound, children older than 5 years with day and
nighttime incontinence, or children at puberty with persistent enuresis.
Figure 2. A 6-year old female child with spinning top urethra and right grade 4 VUR on VCUG.
In patients with suspicion of anatomical abnormalities of the lower urinary tract, a diagnos‐
tic cystoscopy may be performed. Routine diagnostic cystoscopy is not recommended [52].
Urodynamic  evaluation  remains  an  uncomfortable  test  for  children.  Cooperation  of  the
child and the narrow size of the urethra are the major hurdles.  A relaxed child-friendly
environment and patience on the part of the technician are paramount. Full urodynamic
studies  are  considered  invasive  and  should  be  reserved  for  children  with  neurogenic
bladder  dysfunction,  severe  DV,  myogenic  failure,  or  symptoms  that  do  not  improve
with therapy [8,  52].  Urodynamic criteria  for  DV include too large or small  bladder ca‐
pacity, poor bladder compliance, detrusor overactivity or premature contractions, an un‐
sustained  voiding  contraction,  excessive  voiding  pressure,  an  intermittent  uroflow
pattern, or elevated residual urine.
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6. Treatment of DV
Urotherapy is the nonsurgical, nonpharmacologic treatment of lower urinary tract function
and can be defined as a bladder re-education or rehabilitation program aiming at correction
of filling and voiding difficulties. Standard urotherapy is a combination of informing the
child and the family about the normal lower urinary tract function and what is abnormal in
the patient’s voiding and correcting the abnormal voiding habits, lifestyle with regard to flu‐
id intake and diet.
In the setting of discomfort with voiding or dysuria, all efforts should be made to eliminate
any dietary irritants, such as caffeine, carbonated beverages, citrus juices, and chocolate.
Furthermore, skin care should be initiated in children with eroded or irritated perineal areas
from incontinence.
Education emphasizing timed voiding, fluid management, and pelvic floor exercises are key
components of the initial management for DV. In addition, education concerning proper
posture during voiding should be emphasized to minimize abdominal musculature strain‐
ing. Proper sitting technique with buttock and foot support and comfortable hip position is
necessary to enable voiding without recruitment of the abdominal muscles [53, 54]. Hygiene
education is also important to limit local skin inflammation that may contribute to holding
maneuvers and DV. In this way, coordinated voiding with a relaxed pelvic floor can be fa‐
cilitated at the initiation of management.
Treatment of constipation is also important component of the initial management for DV
[55]. Fecal impaction must be managed prior to maintenance therapy. For this purpose laxa‐
tives, stool softeners, and enemas is recommended. Maintenance with balanced diet, fibre
supplementation, and oral medications such as mineral oil, polyethylene glycol and lactu‐
lose are recommended to maintain a goal of one bulky bowel movement a day. Treatment of
constipation alone has been shown to resolve lower urinary tract abnormalities. Enuresis re‐
solved in 63% and daytime incontinence in 89% of patients presenting with constipation and
incontinence in one study [56]. In the same study, resolution of constipation also resolved
recurrent UTIs.
Biofeedback therapy is the next line of treatment after conservative approaches have been
initiated. Biofeedback is a specific treatment modality that aims to retrain the patient’s void‐
ing with the assistance of a computer game. Biofeedback has been used in children as young
as four years of age [57]. There is no standard protocol for the correct teaching of biofeed‐
back, but in general there are 2 methods. Real-time uroflowmetry allows the patient to view
the urine flow rate that in turn can be used to teach the child to relax his/her pelvic floor
musculature with voiding. This method is recommended in children with pelvic floor hy‐
peractivity and no OAB symptoms. Sphincter or pelvic floor electromyography can also be
used to teach patients how to voluntarily control their pelvic floor musculature during void‐
ing and thus reduce or prevent detrusor-sphincter incoordination. The advantage in using
this method lies in its ability to teach a guarding reflex in addition to the relaxation of the
pelvic floor during voiding.
Developments Regarding Dysfunctional Voiding and Urinary Tract Infections in Children 11
Improvement in incontinence, UTIs, VUR, and constipation with biofeedback therapy is
well documented in the literature. Upwards of 80% children will experience improvement
marked by a reduction in incontinence and recurrent urinary infection [58] (Figure 3). Fac‐
tors that have been found to improve efficacy of biofeedback include compliance, normal
bladder capacity, number of sessions, and use of animation. Independent risk factors to pre‐
dict failure identified by Herndon and colleagues are small bladder capacity and compliance
to therapy [40]. Results appear durable at three years and the treatment also seems to help
those children in whom urotherapy has failed [59]. The inclusion of biofeedback in urothera‐
py is more likely to lead to an improvement in residual urine [60].
For patients who fail to respond to the above conservative measures, medical therapy is of‐
ten helpful. Anticholinergic agents serve to decrease detrusor overactivity and increase
functional bladder capacity in patients with urge syndrome or a detrusor overactivity. Anti‐
cholinergics have been shown to provide effective long-term management of detrusor over‐
activity and may also contribute to a quicker resolution of VUR in the setting of DV [61, 62].
Figure 3. The results of the biofeedback after 4 sessions of treatment in the same child;  the appearance of ure‐
thra normalized,  right  grade 4 VUR disappeared on VCUG,  and flow curve and EMG activity  became normal  on
Uroflow-EMG.
For patients with small bladder capacity and low PVR in which DV did not improve with 3
sessions of biofeedback, oxybutynin is effective. For children with small capacity bladders
and high PVR, a full biofeedback session is often necessary to isolate pelvic floor muscles
and lower PVR before initiation of anticholinergics. About 87% of these patients with small-
capacity bladders who do not improve with biofeedback will improve with the addition of
anticholinergics [40].
Clean intermittent catheterization (CIC) has been shown to be useful in children with high
PVR volumes or myogenic failure that do not improve with standard therapy. This thera‐
peutic approach has become routine in many patients with DV of various aetiologies. Pohl
et al. [63] described their experience with using CIC in the treatment of dysfunctional void‐
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ing with a large post-void residual urine volume. It proved to be well tolerated and allowed
patients to rapidly attain continence and eliminate recurrent UTI by achieving more effec‐
tive bladder emptying.
Alpha-adrenergic blockade of receptors at the bladder neck and urethra results in relaxation
of smooth muscle and theoretically enables more complete bladder emptying. Although the
results have been somewhat mixed, several studies have shown efficacy in reducing subjec‐
tive symptoms and improving objective urinary parameters in children with DV and in‐
creased PVR [64, 65]. Dramatic improvement in flow, initiation of voiding, and PVR was
documented in one study by Donohoe and colleagues [66]. All children that met the criteria
of primary bladder neck dysfunction (low flow rate, low EMG activity, and delayed initia‐
tion of voiding) improved with alpha-blocker therapy and those that discontinued therapy
returned to baseline symptoms.
The transurethral injection of botulinum toxin into the striated urethral sphincter has been
beneficial in spinal cord injury patients with detrusor sphincter dyssynergia [67]. Several
small studies have demonstrated improvement [68-70]. Botulinum toxin has also been pro‐
posed as a potentially new treatment regimen to improve bladder emptying for children
with DV who have failed standard therapy. Petronijevic et al examined the role of combined
the injection of botulinum toxin-A (BTX-A) and biofeedback in the management of the fe‐
male children with DV who were refractory to standard therapy, and analyzed their clinical
outcomes. The dose of 500 units of BTX-A was diluted in 2.5 ml saline and injected transper‐
ineally around the urethral meatus at the 3, 6, 9 and 12 o’clock positions, 1 to 2 cm deep into
the external urinary sphincter. After treatment the mean voided volume increased while
post-void residual urine volume decreased significantly. Significant differences in other uro‐
flowmetry parameters were not found [71]. In another study, Radojicic et al. investigated the
results of BTX-A into the urethral sphincter and/or pelvic floor muscle injection combined
with behavioural and biofeedback therapy in children with DV resistant to previous treat‐
ments, including behavioural, biofeedback and alpha-blockers in 8 boys and 12 girls. The
dose of 100 IU BTX-A was diluted in 4 ml saline and injected by a transperineal 21 or 23
gauge needle in the pelvic floor, including the external sphincter. Six months after treatment
residual urine decreased significantly in 17 of 20 patients. Nine patients re-established a nor‐
mal voiding curve and 8 showed improvement. Three did not manifest any significant im‐
provement [72]. The limitations of the studies advocating the use of botulinum toxin are
small sample size, lack of standard dosing, and nonrandomization.
Sacral neuromodulation has been successful in children with refractory DV, but the invasive‐
ness of this modality has limited its use in children without neurologic deficits [73]. Its feasibili‐
ty and efficacy has been well demonstrated [74]. Storage symptoms resolve in about three-
fourths  of  children  [74].  The  response  of  DV  to  neuromodulation  with  the  Interstim
neuromodulation device was modest. In a single centre study, urinary incontinence, urgency
and frequency, nocturnal enuresis and constipation were improved or resolved in 88%, 69%,
89%, 69% and 71% of the patients, respectively [74]. In a multi-institutional study, about 60% of
children with voiding difficulty had some benefit [75]. Neuromodulation offers the additional
incentive of a potential improvement in constipation and irritable bowel symptoms [74, 76].
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Less invasive neuromodulatory devices such as tibial nerve stimulation and transcutaneous
electrical nerve stimulation (TENS) have been proposed as treatment modalities. Capitanuc‐
ci et al. evaluated the efficacy of percutaneous tibial nerve stimulation for different types of
paediatric LUTD. A total of 14 children with idiopathic OAB, 14 with DV, 5 with underac‐
tive bladder, 4 with underactive valve bladder and 7 with neurogenic bladder resistant to
conventional therapy underwent percutaneous tibial nerve stimulation weekly for 30 min
on a weekly schedule for 12 weeks. Patients with DV were significantly more likely to bene‐
fit as compared to those with OAB at rates of up to 100 % [77]. TENS has had success in the
treatment of OAB syndrome when compared with placebo in one prospective trial [78]. The
use of neuromodulation as treatment modality in refractory LUTD is promising, but larger
prospective trials will be necessary to solidify its role as a treatment modality.
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